Antonis Vylliotis

1.5k total citations
53 papers, 1.3k citations indexed

About

Antonis Vylliotis is a scholar working on Cancer Research, Oncology and Molecular Biology. According to data from OpenAlex, Antonis Vylliotis has authored 53 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Cancer Research, 28 papers in Oncology and 27 papers in Molecular Biology. Recurrent topics in Antonis Vylliotis's work include Protease and Inhibitor Mechanisms (11 papers), Blood Coagulation and Thrombosis Mechanisms (10 papers) and Cancer-related Molecular Pathways (10 papers). Antonis Vylliotis is often cited by papers focused on Protease and Inhibitor Mechanisms (11 papers), Blood Coagulation and Thrombosis Mechanisms (10 papers) and Cancer-related Molecular Pathways (10 papers). Antonis Vylliotis collaborates with scholars based in Greece, Germany and United States. Antonis Vylliotis's co-authors include Christos Yapijakis, Eleftherios Vairaktaris, Stavros Vassiliou, Spyridoula Derka, Emeka Nkenke, Efstratios Patsouris, Friedrich Wilhelm Neukam, Zoe Serefoglou, Sofia Spyridonidou and Dimitrios Avgoustidis and has published in prestigious journals such as Advances in experimental medicine and biology, Oral Oncology and American Journal of Hematology.

In The Last Decade

Antonis Vylliotis

51 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Antonis Vylliotis Greece 23 493 466 455 202 160 53 1.3k
Spyridoula Derka Greece 21 481 1.0× 418 0.9× 381 0.8× 184 0.9× 149 0.9× 52 1.1k
Stavros Vassiliou Greece 23 496 1.0× 485 1.0× 470 1.0× 208 1.0× 141 0.9× 66 1.3k
Ravindran Ankathil Malaysia 22 251 0.5× 318 0.7× 649 1.4× 92 0.5× 225 1.4× 99 1.3k
Sofia Spyridonidou Greece 15 211 0.4× 232 0.5× 298 0.7× 80 0.4× 50 0.3× 31 663
Li-Zhen Chen China 22 500 1.0× 798 1.7× 587 1.3× 264 1.3× 48 0.3× 38 1.7k
Naoko Okayama Japan 20 288 0.6× 403 0.9× 643 1.4× 188 0.9× 87 0.5× 70 1.3k
Vera Balz Germany 17 145 0.3× 364 0.8× 331 0.7× 192 1.0× 32 0.2× 38 838
Hariklia Gakiopoulou Greece 20 242 0.5× 512 1.1× 654 1.4× 253 1.3× 58 0.4× 54 1.4k
Jan Kornafel Poland 16 144 0.3× 411 0.9× 246 0.5× 182 0.9× 67 0.4× 73 832
Muh‐Hwa Yang Taiwan 16 245 0.5× 456 1.0× 465 1.0× 186 0.9× 44 0.3× 56 1.3k

Countries citing papers authored by Antonis Vylliotis

Since Specialization
Citations

This map shows the geographic impact of Antonis Vylliotis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonis Vylliotis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonis Vylliotis more than expected).

Fields of papers citing papers by Antonis Vylliotis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonis Vylliotis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonis Vylliotis. The network helps show where Antonis Vylliotis may publish in the future.

Co-authorship network of co-authors of Antonis Vylliotis

This figure shows the co-authorship network connecting the top 25 collaborators of Antonis Vylliotis. A scholar is included among the top collaborators of Antonis Vylliotis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonis Vylliotis. Antonis Vylliotis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yapijakis, Christos, Veronica Papakosta, Andreas C. Lazaris, et al.. (2024). EGFR and HER-2 oncogenes expression in an experimental model of two-stage chemically induced carcinogenesis in mouse skin. Journal of Cranio-Maxillofacial Surgery. 52(4). 413–419. 1 indexed citations
2.
Papanikolaou, Vasileios, Aristeidis Chrysovergis, Vasileios Ragos, et al.. (2023). Impact of Amplified Oncogenes on Salivary Gland Carcinomas. Cancer Diagnosis & Prognosis. 3(5). 528–532. 1 indexed citations
3.
Yapijakis, Christos, et al.. (2021). Phenotype and Genotype Study in a Case of Frontometaphyseal Dysplasia 1. Advances in experimental medicine and biology. 1339. 319–323.
4.
Yapijakis, Christos, Alexander Katoulis, Dimitrios Avgoustidis, et al.. (2020). Association study indicates combined effect of interleukin-10 and angiotensin-converting enzyme in basal cell carcinoma development. Archives of Dermatological Research. 313(5). 373–380. 5 indexed citations
5.
Yapijakis, Christos, Sofia Spyridonidou, Antonis Vylliotis, et al.. (2013). Association of angiotensin-converting enzyme gene insertion/deletion polymorphism with decreased risk for basal cell carcinoma. Archives of Dermatological Research. 305(4). 333–339. 15 indexed citations
6.
Vylliotis, Antonis, Christos Yapijakis, Emeka Nkenke, et al.. (2013). Effect of thrombosis-related gene polymorphisms upon oral cancer: a regression analysis.. PubMed. 33(9). 4033–9. 20 indexed citations
7.
Yapijakis, Christos, Zoe Serefoglou, Antonis Vylliotis, et al.. (2009). Association of polymorphisms in Tumor Necrosis Factor Alpha and Beta genes with increased risk for oral cancer.. PubMed. 29(6). 2379–86. 39 indexed citations
8.
Spyridonidou, Sofia, Christos Yapijakis, Emeka Nkenke, et al.. (2009). A common 9 bp deletion in the ataxia-telangiectasia-mutated gene is not associated with oral cancer.. PubMed. 29(8). 3191–3. 2 indexed citations
9.
Yapijakis, Christos, Emeka Nkenke, Zoe Serefoglou, et al.. (2008). Association of leptin −2548G/A and leptin receptor Q223R polymorphisms with increased risk for oral cancer. Journal of Cancer Research and Clinical Oncology. 135(4). 603–612. 38 indexed citations
10.
Vairaktaris, Eleftherios, Zoe Serefoglou, Dimitrios Avgoustidis, et al.. (2008). Gene polymorphisms related to angiogenesis, inflammation and thrombosis that influence risk for oral cancer. Oral Oncology. 45(3). 247–253. 51 indexed citations
11.
Vairaktaris, Eleftherios, Christos Yapijakis, Zoe Serefoglou, et al.. (2008). Gene expression polymorphisms of interleukins-1β, -4, -6, -8, -10, and tumor necrosis factors-α, -β: regression analysis of their effect upon oral squamous cell carcinoma. Journal of Cancer Research and Clinical Oncology. 134(8). 821–832. 57 indexed citations
12.
Vairaktaris, Eleftherios, Sofia Spyridonidou, Christos Yapijakis, et al.. (2007). Abundance and localization of skeletal muscle-related erbB2 may stimulate tumour growth during initial stages of oral oncogenesis.. PubMed. 7(2). 185–90. 4 indexed citations
13.
Vairaktaris, Eleftherios, Stavros Vassiliou, Emeka Nkenke, et al.. (2007). EGFR and c-Jun exhibit the same pattern of expression and increase gradually during the progress of oral oncogenesis.. PubMed. 21(5). 791–6. 8 indexed citations
14.
Vairaktaris, Eleftherios, Zoe Serefoglou, Christos Yapijakis, et al.. (2007). Coagulation-related factors, thrombomodulin and protein Z, are not associated with risk for oral cancer.. PubMed. 27(4B). 2449–51. 4 indexed citations
15.
Vairaktaris, E, Sofia Spyridonidou, Veronica Papakosta, et al.. (2007). The hamster model of sequential oral oncogenesis. Oral Oncology. 44(4). 315–324. 87 indexed citations
16.
Vairaktaris, Eleftherios, Georgios Papageorgiou, Spyridoula Derka, et al.. (2006). Expression of ets-1 is not affected by N-ras or H-ras during oral oncogenesis. Journal of Cancer Research and Clinical Oncology. 133(4). 227–233. 11 indexed citations
17.
Vairaktaris, Eleftherios, Christos Yapijakis, Zoe Serefoglou, et al.. (2006). Plasminogen activator inhibitor-1 polymorphism is associated with increased risk for oral cancer. Oral Oncology. 42(9). 888–892. 55 indexed citations
18.
Vairaktaris, E, Antonis Vylliotis, Christos Yapijakis, et al.. (2006). Strong Association of Interleukin-6 -174 G>C Promoter Polymorphism with Increased Risk of Oral Cancer. The International Journal of Biological Markers. 21(4). 246–250. 28 indexed citations
19.
Vairaktaris, Eleftherios, Christos Yapijakis, Zoe Serefoglou, et al.. (2006). The interleukin-8 (−251A/T) polymorphism is associated with increased risk for oral squamous cell carcinoma. European Journal of Surgical Oncology. 33(4). 504–507. 67 indexed citations
20.
Vairaktaris, Eleftherios, Christos Yapijakis, Jörg Wiltfang, et al.. (2005). Are factor V and prothrombin mutations associated with increased risk of oral cancer?. PubMed. 25(3c). 2561–5. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026